Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belara extended-cycle versus conventional-cycle oral contraception study
2004-002076-42Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Nov 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of chlormadinone acetate in contraception (2 arms), sponsored by Grünenthal GmbH. Primary endpoint: Intermenstrual bleeding days proportion during 392 days. Started Nov 2005; status: completed.
02
Drugs
chlormadinone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on 2004-002076-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002076-42.